Editorial director, Beghou Consulting; dad/husband; hobbies: sports, writing about pharmaceuticals.
Northern New Jersey
Joined June 2009
- Tweets1.3K
- Following365
- Followers934
- Likes907
In quest for a 1-time treatment for autoimmune disease, what level of risk is acceptable? Novartis CAR-T deaths have raised questions - endpoints.news/novartis-car-…
Check out my latest article: How pharma marketers can prepare for Trump’s 200% #tariff threat linkedin.com/pulse/how-pharm… via @LinkedIn
Check out my latest article: What the #asco2025 exhibit hall says about biopharma’s shifting #Oncology agenda linkedin.com/pulse/what-asco… via @LinkedIn
Check out my latest article: What Databricks’ latest deal means for pharma’s AI aspirations linkedin.com/pulse/what-data… via @LinkedIn
Looking forward to a great afternoon at this year's #MMM40Under40 at the Edison Ballroom in NYC.
Worth a listen: My colleague @imjackobrien gets the 4 major health highlights from #CES2025 according to pharma/journo vet @alisonwoo: mmm-online.com/home/podcasts…
Article by my colleague @Lecia_Bushak on why @DaiichiSankyoUS launched a DTC ad for its cancer drug during #NFL's Thurs. Night Football: mmm-online.com/home/channel/…
Great piece by my colleague @Lecia_Bushak on RFK Jr.'s spasmodic dysphonia. I first learned about SD while writing for a speech-pathology mag in the '90s. Amazed #botox is still the go-to treatment option...mmm-online.com/home/channel/…
Great op/ed by my colleague @AlisonWeissbrot: AI requires a rethink of the agency biz model. Should digital assistants be paid like FTEs? Health marketing agencies starting to grapple with this, too. campaignlive.com/article/ai-… via @campaignliveus
I wrote about Parkinson's. Does that negate the importance of Alzheimer's? No. But when it comes to social issues, communicators risk being called out unless they speak to all points of view. @Gil_Bashe explains “whataboutism” + why it may kill empathy medika.life/is-whataboutism-…
It's Neal Awards season + @MMMnews grabbed a nom for best single issue. What a nod to the way this team goes about meeting its far-reaching editorial remit. (Oh, and I'll be chasing another one of these myself.) Thank you, @SIIA mmm-online.com/home/channel/…
My colleague @LeciaBushak interviews @CDCgov director @DrMandyCohen on how the agency plans to improve public health messaging in a post-COVID world for @MMMnews mmm-online.com/home/channel/…
Major dev. in copay accumulator case, as #DOJ withdraws appeal of '23 decision that vacated #HHS rule allowing insurers not to count mfr. copay assistance toward beneficiary's deductible/OOP max. Plaintiffs claim this effectively ends accumulators. hivhep.org/press-releases/go…
Arrived today for #JPM24. Looking forward to the delight of seeing + speaking with colleagues, and for the exhilaration of being ‘on the ground’ during one of the year’s most newsworthy weeks.
Inside Bayer’s embrace of generative AI mmm-online.com/home/channel/… #7DaySupply @MMMnews @07saskia
While 5% was once a dream, medicines now help people shed 20% or more body mass. Drug co's say quality, not magnitude, is their next frontier: mmm-online.com/home/channel/… @mmmne
Yes, says @RosenthalHealth, the term 'journey' has run amok in healthcare marketing, and it underscores a larger problem: mmm-online.com/home/channel/…
For those thinking of watching #Netflix's Pain Hustlers flick, @imjackobrien will have a review on this wk's @MMMnews podcast. For context, back in 2019, the Insys Therapeutics case was a 'punitive turning point' for #pharmamarketing mmm-online.com/home/opinion/…
Israel-Hamas war marks a CEO commentary sea change: mmm-online.com/home/channel/…